Quotient Sciences Quotient Sciences

X

Find US Patent Information with US Patent Number, Application Number and Patent Expiration Date of Dacomitinib on PharmaCompass.com

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
8623883
2025-05-05
U-1403
211288
FIRST-LINE TREATMENT OF METASTATIC NON SMAL-CELL LUNG CANCER (NSCLC) WITH EGFR EXON 19 DELETIONS OR EXON 21 (L858R) SUBSTITUTION MUTATIONS AS DETECTED
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
10596162
2026-02-02
U-3338
211288
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
10603314
2026-02-02
U-3337
211288
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
8623883
2025-05-05
U-1403
211288
FIRST-LINE TREATMENT OF METASTATIC NON SMAL-CELL LUNG CANCER (NSCLC) WITH EGFR EXON 19 DELETIONS OR EXON 21 (L858R) SUBSTITUTION MUTATIONS AS DETECTED
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
10603314
2026-02-02
U-3337
211288
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
10596162
2026-02-02
U-3338
211288
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
7772243
Y
Y
2028-08-26
211288
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
10596162
2026-02-02
U-3338
211288
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
8623883
2025-05-05
U-1403
211288
FIRST-LINE TREATMENT OF METASTATIC NON SMAL-CELL LUNG CANCER (NSCLC) WITH EGFR EXON 19 DELETIONS OR EXON 21 (L858R) SUBSTITUTION MUTATIONS AS DETECTED
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
10603314
2026-02-02
U-3337
211288
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
7772243
Y
Y
2028-08-26
211288
3
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
7772243
Y
Y
2028-08-26
211288
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY